Skip to main content
Jennifer L. Pauley, BS, PharmD, BCPS, BCOP

Jennifer L. Pauley, BS, PharmD, BCPS, BCOP

  • Director, Global Pharmacy
  • Assistant Professor, The University of Tennessee Health Sciences Center, Department of Clinical Pharmacy and Translational Science


Board Certification(s)

  • BCPS
  • BCOP

Education & Training

  • BSPharm – The Ohio State University, Columbus, Ohio
  • PharmD - The Ohio State University, Columbus, Ohio
  • Residency – Pediatric Pharmacotherapy, Texas Children’s Hospital

Focused Area of Practice

  • Global Pharmacy Education
  • Leukemia/Lymphoma

Honors & Awards

  • 2020  Clinical Care Improvement Award for Clinical Pharmacy Services, St. Jude Children’s Research Hospital
  • 2016  Clinical Care Improvement Award for Antimicrobial Stewardship Program, St. Jude Children’s Research Hospital

Research Interests

  • Global Pharmaceutical Care
  • Leukemia/Lymphoma
  • Preceptor Development

St. Jude Committee Service

  • Antimicrobial Utilization and Improvement

Pharmacy Organizations/Committee Service

  • American College of Clinical Pharmacy
  • American Pharmacists Association
  • American Society of Health-System Pharmacists 
  • Children’s Oncology Group 
  • Hematology/Oncology Pharmacy Association 
  • International Pharmaceutical Federation
  • International Society of Oncology Pharmacy Practitioners
  • International Society of Paediatric Oncology
  • MidSouth College of Clinical Pharmacy 
  • Pediatric Pharmacy Association
  • Tennessee Pharmacists Association 

Selected Publications

Gaietto A, Panetta JC, Pauley JL, et al. Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children’s Research Hospital. Cancer Chemother Pharmacol. Feb 28, 2024.

King MA, Cross SJ, Morton TH, Hijano DR, Greene WL, Sun Y, Tang L, Pauley JL, et al. Evaluation of continuous infusion vancomycin in a pediatric hematology/oncology population. Pediatr Infect Dis J. Feb 12, 2024.

Smith T, Mills K, Cober MP, Fenn NE 3rd, Hill C, King M, Pauley JL, et al. Updates in the treatment of asthma in pediatrics: A review for pharmacists. Am J Health Syst Pharm. Dec 26, 2023.

Mills K, Hill C, King M, Pauley JL, et al. Just DOAC: Use of direct-acting oral anticoagulants in pediatrics. Am J Health Syst Pharm. 2023 Mar 21;80(7):412-22.

Gruber TA, Pei D, Choi J, Cheng C, Coustan-Smith E, Campana D, Swanson HD, Pauley JL, et al. Clofarabine treatment of KMT2Ar infantile patients with acute lympoblastic leukemia in St. Jude Total Therapy Study 16. Blood Adv. 2022 Dec 27;6(24):6131-34.

Sauer HE, Crews KR, Pauley JL, et al. Evaluation of aminophylline for the treatment of acute kidney injury in pediatric hematolog/oncology patients, J Pediatr Pharmacol. 2021;26(5):484-90.

Lambrix AA, Swanson HD, Pauley JL, et al. Experience using intravenous Posaconazole in paediatric and young adult oncology patients. J Antimicrob Chemother. 2020 Dec 1;75(12):3682-87.

Quinn M, Fannin JT, Sciasci J, Bragg A, Campbell PK, Carias D, Crews KR, Gregornik D, Jeha S, Maron G, Pauley JL, et al. Pentamidine for prophylaxis against pneumocystis jirovecii pneumonia in pediatric oncology patients receiving immunosuppressive chemotherapy. Antimicrob Agents Chemother. 2018 Jul 27;62(8).

Ramsey LB, Balis FM, O’Brien MM, Schmeigelow K, Pauley JL, et al. Consensus guidelines for the use of glucarpidase in patients with high-dose methotrexate induced acute kidney injury an delayed methotrexate excretion. Oncologist. 2018 Jan;23(1):52-61.

Millisor VE, Roberts JK, Sun Y, Tang L, Daryani VM, Gregornik D, Cross, SJ, Ward D, Pauley JL, et al. Derivation of new equations to estimate glomerular filtration rate in pediatric oncology patients. Pediatr Nephrol. 2017 Sep;32(9):1575-84.

Watts CS, Sciasci JN, Pauley JL, Panetta JC, et al. Prophylactic trimethoprim-sulfamethoxazole does not affect pharmacokinetics or pharmacodynamics of methotrexate. J Pediatr Hematol Oncol. 2016 Aug;38(6):449-52.

Pauley JL, Panetta JC, Crews KR, et al. Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments. Cancer Chemother Pharmacol. 2013 Aug;72(2):369-78.

Bernardo VA, Cross SJ, Crews KR, Flynn PM, Hoffman JM, Knapp KM, Pauley JL, et al.  Posaconazole therapeutic drug monitoring in pediatric patients and young adults with cancer.  Ann Pharmacother. 2013 Jul;47(7-8):976-83.

Buaboonnam J, Cao X, Pauley JL, Pui CH, et al. Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric acute myeloid leukemia. Pediatr Blood Cancer. 2013 Jul;60(7):1161-4.

Christensen AM, Pauley JL, Molinelli AR, et al. Resumption of high-dose methotrexate after acute kidney injury and glucarpidase use in pediatric oncology patients. Cancer. 2012 Sep 1;118(17):4321-30.

Inaba H, Bhojwani D, Pauley JL, et al. Combination chemotherapy with clofarabine, cyclophosphamide and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol. 2011 Aug 25.

Anghelescu DL, Faughnan LG, Jeha S, Relling MV, Hinds PS, Sandlund JT, Cheng C, Pei D, Hankins G, Pauley JL, Pui CH. Neuropathic pain during treatment for childhood acute lymphoblastic leukemia. Pediatr Blood Cancer, 2011 Dec 15;57(7):1147-53.

Crews KR, Zhou Y, Pauley JL, Howard SC, Jeha S, Relling MV, Pui CH. Effect of allopurinol versus urate oxidase on methotrexate pharmacokinetics in children with newly diagnosed acute lymphoblastic leukemia. Cancer, 2010 Jan 1;116(1):227-32.

Brugnoletti F, Morris EB, Laningham FH, Patay Z, Pauley JL, Pui CH, Jeha S, Inaba H.  Recurrent intrathecal Methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings. Pediatr Blood Cancer, 2009 52(2):293-5.

Pauley JL, Panetta JC, et al.  Late-Onset Delayed Excretion of Methotrexate.  Cancer Chemother Pharmacol, 2004(54):146-152.

Last update: March 2024